Weijun Chen
Director, Rna Technologies Lead Intellia Therapeutics
Seminars
Wednesday 23rd July 2025
Advances in Therapeutic Genome Editing with Cas9 mRNA
1:15 pm

Director, Rna Technologies Lead Intellia Therapeutics